Artwork
iconShare
 
Manage episode 486552389 series 3547924
Content provided by Mary. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Mary or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Chad and Mary welcome Chris Hansen, PhD, Divisional General Manager for the Rare Disease Medical Affairs team, East, with Sanofi. This conversation explores the transition from traditional metrics to a more meaningful impact-driven approach in the field. Chris shares his journey, insights on the importance of both qualitative and quantitative metrics, and how to drive meaningful interactions with healthcare professionals. The discussion emphasizes the need for a holistic view of success in medical affairs, integrating both types of metrics to truly assess impact. In this conversation, Chris Hansen discusses the evolving landscape of medical affairs metrics, emphasizing the need for a holistic approach to measuring success.

  continue reading

52 episodes